731810-56-3 Usage
General Description
Methyl 6-N-BOC-aminoindole-4-carboxylate is a chemical compound that belongs to the class of aminoindole derivatives. It is commonly used as an intermediate in the synthesis of pharmaceuticals, agrochemicals, and other organic compounds. The "6-N-BOC" in the name indicates that the nitrogen atom of the indole ring is protected with a BOC (tert-butoxycarbonyl) group, which helps to control the reactivity and selectivity of the compound in chemical reactions. The methyl ester group at the 6-position of the indole ring indicates the presence of a methyl group attached to the carboxylate group, which can influence the compound's solubility and stability. Overall, Methyl 6-N-BOC-aminoindole-4-carboxylate is a versatile building block with important applications in organic synthesis.
Check Digit Verification of cas no
The CAS Registry Mumber 731810-56-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 7,3,1,8,1 and 0 respectively; the second part has 2 digits, 5 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 731810-56:
(8*7)+(7*3)+(6*1)+(5*8)+(4*1)+(3*0)+(2*5)+(1*6)=143
143 % 10 = 3
So 731810-56-3 is a valid CAS Registry Number.
InChI:InChI=1/C15H18N2O4/c1-15(2,3)21-14(19)17-9-7-11(13(18)20-4)10-5-6-16-12(10)8-9/h5-8,16H,1-4H3,(H,17,19)
731810-56-3Relevant articles and documents
COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH STING ACTIVITY
-
Page/Page column 192, (2020/12/30)
This disclosure features chemical entities (e.g., a compound or a pharmaceutically acceptable salt, and/or hydrate, and/or cocrystal, and/or drug combination of the compound) that inhibit (e.g., antagonize) Stimulator of Interferon Genes (STING). Said chemical entities are useful, e.g., for treating a condition, disease or disorder in which increased (e.g., excessive) STING activation (e.g., STING signaling) contributes to the pathology and/or symptoms and/or progression of the condition, disease or disorder (e.g., cancer) in a subject (e.g., a human). This disclosure also features compositions containing the same as well as methods of using and making the same.
POLYMORPHIC FORMS OF (2R,Z)-2-AMINO-2-CYCLOHEXYL-N-(5-(1-METHYL-1H-PYRAZOL-4ΥL)-1-OXO-2,6-DIHYDRO-1H-[1,2]DIAZEPINO[4,5,6-CD]INDOL-8-YL)ACETAMIDE
-
Page/Page column 9; 20-21, (2008/06/13)
The present invention relates to novel polymorphic forms and amorphous form of (2R,Z)-2-amino-2-cyclohexyl-N-(5-(1-methyl-1H-pyrazol-4-yl)-1-oxo-2,6-dihydro-1H-[1,2]diazepino[4,5,6-cd]indol-8-yl)acetamide, and to processes for their preparation. Such poly
